Literature DB >> 12232787

Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population.

K Brophy1, Z Hawi, A Kirley, M Fitzgerald, M Gill.   

Abstract

Several lines of evidence have suggested that ADHD is a polygenic disorder produced by the interaction of several genes each of a minor effect. Synaptosomal-associated protein 25 (SNAP-25) is a presynaptic plasma membrane protein which is expressed highly and specifically in the nerve cells. The gene encodes a protein essential for synaptic vesicle fusion and neurotransmitter release. Animal model studies showed that the coloboma mouse mutant has a hyperactive phenotype similar to that of ADHD. The hyperactive phenotype of this model has been shown to be the result of a deletion of the SNAP-25 gene. DNA variations within or closely mapped to the SNAP-25 gene may alter the level of expression and hence may have an effect on the function of synaptic vesicle fusion and neurotransmitter release. Using HHRR and TDT we analysed 93 ADHD nuclear families from Ireland and found increased preferential transmission of SNAP-25/DdeI allelel to ADHD cases; HHRR (chi(2) = 6.55, P = 0.01) and linkage (TDT) (chi(2) = 6.5, P = 0.015). In contrast to our findings, Barr et al(1) reported an increased transmission of allele 2 of the DdeI polymorphism though this was not statistically significant. However, they also reported a significantly increased transmission of a haplotype (made of allele 1 of MnlI and allele 2 of the DdeI) in their Canadian ADHD sample. It is not clear what the role of SNAP-25 in ADHD is until these findings are either confirmed or refuted in other ADHD samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12232787     DOI: 10.1038/sj.mp.4001092

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  46 in total

1.  BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain.

Authors:  Reza Pourhaghighi; Peter E A Ash; Sadhna Phanse; Florian Goebels; Lucas Z M Hu; Siwei Chen; Yingying Zhang; Shayne D Wierbowski; Samantha Boudeau; Mohamed T Moutaoufik; Ramy H Malty; Edyta Malolepsza; Kalliopi Tsafou; Aparna Nathan; Graham Cromar; Hongbo Guo; Ali Al Abdullatif; Daniel J Apicco; Lindsay A Becker; Aaron D Gitler; Stefan M Pulst; Ahmed Youssef; Ryan Hekman; Pierre C Havugimana; Carl A White; Benjamin C Blum; Antonia Ratti; Camron D Bryant; John Parkinson; Kasper Lage; Mohan Babu; Haiyuan Yu; Gary D Bader; Benjamin Wolozin; Andrew Emili
Journal:  Cell Syst       Date:  2020-04-22       Impact factor: 10.304

Review 2.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

3.  Synaptosomal-associated protein 25 gene polymorphisms and antisocial personality disorder: association with temperament and psychopathy.

Authors:  Cengiz Basoglu; Ozgur Oner; Alpay Ates; Ayhan Algul; Yasin Bez; Mesut Cetin; Hasan Herken; Mehmet Emin Erdal; Kerim M Munir
Journal:  Can J Psychiatry       Date:  2011-06       Impact factor: 4.356

4.  Association among SNAP-25 gene DdeI and MnlI polymorphisms and hemodynamic changes during methylphenidate use: a functional near-infrared spectroscopy study.

Authors:  Özgür Öner; Ata Akın; Hasan Herken; Mehmet Emin Erdal; Koray Çiftçi; Mustafa Ertan Ay; Duygu Bicer; Bedriye Öncü; Ozlem Hekim Bozkurt; Kerim Münir; Yankı Yazgan
Journal:  J Atten Disord       Date:  2010-08-02       Impact factor: 3.256

5.  Minor differences in the molecular machinery mediating regulated membrane fusion has major impact on metabolic health.

Authors:  Ismael Valladolid-Acebes; Teresa Daraio; Kerstin Brismar; Tomas Hökfelt; Christina Bark
Journal:  Adipocyte       Date:  2016-01-08       Impact factor: 4.534

Review 6.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

7.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

8.  Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11.

Authors:  Matthew N Ogdie; Simon E Fisher; May Yang; Janeen Ishii; Clyde Francks; Sandra K Loo; Rita M Cantor; James T McCracken; James J McGough; Susan L Smalley; Stanley F Nelson
Journal:  Am J Hum Genet       Date:  2004-08-03       Impact factor: 11.025

9.  Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.

Authors:  Ilja Spellmann; Norbert Müller; Richard Musil; Peter Zill; Anette Douhet; Sandra Dehning; Anja Cerovecki; Brigitta Bondy; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03-17       Impact factor: 5.270

10.  Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes.

Authors:  Naomi Lowe; Aiveen Kirley; Ziarih Hawi; Pak Sham; Harvey Wickham; Christopher J Kratochvil; Shelley D Smith; Saretta Y Lee; Florence Levy; Lindsey Kent; Fiona Middle; Luis A Rohde; Tatiana Roman; Eda Tahir; Yanke Yazgan; Philip Asherson; Jonathan Mill; Anita Thapar; Antony Payton; Richard D Todd; Timothy Stephens; Richard P Ebstein; Iris Manor; Cathy L Barr; Karen G Wigg; Richard J Sinke; Jan K Buitelaar; Susan L Smalley; Stan F Nelson; Joseph Biederman; Stephen V Faraone; Michael Gill
Journal:  Am J Hum Genet       Date:  2004-01-19       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.